Jeffrey Harris
Family Medicine · Greenville, SCNPI 1215134978
Payments from drug & device makers
Across 349 payments — averaging $9744.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$757K
- Quidel Corporation$528K
- Covis Pharma GmbH$465K
- Gen-probe, Inc.$457K
- BD$308K
- Orasure Technologies Inc.$232K
- plus $652K from 27 others
Across 4 payments — averaging $24,121 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- BD$96K
What the payments were for
- Speaking & faculty fees$1,00024%
- Food & beverage$3,22376%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $757,435 |
| Quidel Corporation | 15 | $528,492 |
| Covis Pharma GmbH | 2 | $465,163 |
| Gen-probe, Inc. | 24 | $456,744 |
| BD | 25 | $308,399 |
| Orasure Technologies Inc. | 18 | $232,407 |
| Diasorin Molecular LLC | 1 | $194,821 |
| Roche Molecular Systems, Inc. | 18 | $115,594 |
| Rapid Pathogen Screening, Inc. | 18 | $109,891 |
| Ortho-clinical Diagnostics, Inc. | 10 | $106,733 |
| Evofem Biosciences, Inc. | 14 | $76,115 |
| Partner Therapeutics, Inc. | 5 | $30,143 |
| Genentech, Inc. | 1 | $14,700 |
| Indivior Inc. | 11 | $1,191 |
| Supernus Pharmaceuticals, Inc. | 56 | $780 |
| Tris Pharma Inc | 29 | $467 |
| Ironshore Pharmaceuticals Inc. | 27 | $467 |
| Corium, LLC | 16 | $307 |
| Neos Therapeutics, LP | 12 | $237 |
| AbbVie | 6 | $130 |
| Noven Therapeutics, LLC | 4 | $90 |
| Adlon Therapeutics L.p. | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| AstraZeneca | 3 | $51 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Genentech USA, Inc. | 1 | $22 |
| Rhodes Pharmaceuticals L.p. | 1 | $21 |
| Braeburn Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Pfizer | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUBLOCADE$1,000
- Proclaim Family of SCS IPGs$180
How this compares
$3,400,680 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $2,039 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Greenville
- James FranklinGreenville$3.5M
- Christopher DavisGreenville$2.7M
- Harlicia FarleyGreenville$1.1M
- James WallaceGreenville$708K
- Eric Garcia-TorresGreenville$102K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- Stephen GrubbLittle River$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.